<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01854086</url>
  </required_header>
  <id_info>
    <org_study_id>MMC130009-13CTIL</org_study_id>
    <nct_id>NCT01854086</nct_id>
  </id_info>
  <brief_title>Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday</brief_title>
  <acronym>CONTINUITY</acronym>
  <official_title>Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday: Data From a Single Outpatient Endocrine Clinic.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to provide information about the rate of response and persistence
      to drug therapies for osteoporosis. Another issue examined in this study refers to the
      preferences and concerns about future treatments in patients during &quot;drug holiday&quot;.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2013</start_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Compliance and persistence to osteoporosis drug therapy</measure>
    <time_frame>Participants will be followed for the duration of their clinic visit, an average of 5 hours</time_frame>
    <description>Data collection will be done by questionnaires and from the medical record of the patient. The information collected will include: demographic information, measurements of bone density, additional information about the disease and treatment that the patient receives,prescription purchases and additional drugs the patient is taking (steroids, PPI's(Proton Pump Inhibitors) / H2 receptor antagonists and NSAIDs(Non Steroidal Anti Inflammatories)).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>Postmenopausal women</arm_group_label>
    <description>Postmenopausal women treated with bisphosphonates</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires about compliance and persistence with bisphosphonates treatment</intervention_name>
    <arm_group_label>Postmenopausal women</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with osteoporosis,who been treated in Endocrinology Clinic of Medical Center
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Postmenopausal women

          -  Diagnosis of osteoporosis in the medical record

          -  At least one prescription drug to treat osteoporosis in the last 5 years

          -  Insured by &quot;Clalit&quot; Health Services

          -  Hebrew-speaking capability and readiness to answer a questionnaire

        Exclusion Criteria:

          -  Premenopausal women

          -  No diagnosis of osteoporosis in the medical record

          -  No treatment for osteoporosis in the last 5 years

          -  Women who do not speak Hebrew or are unable to answer a questionnaire
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pnina Rotman, M.D</last_name>
    <phone>972-57-7482609</phone>
    <email>Pnina.Rotman@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Meir medical center the clalit health care services group</name>
      <address>
        <city>Kfar Saba</city>
        <zip>44281</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pnina Rotman, M.D</last_name>
      <phone>972-57-7482609</phone>
      <email>Pnina.Rotman@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Pnina Rotman, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <results_reference>
    <citation>Cramer JA, Amonkar MM, Hebborn A, Altman R. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin. 2005 Sep;21(9):1453-60.</citation>
    <PMID>16197664</PMID>
  </results_reference>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2013</study_first_submitted>
  <study_first_submitted_qc>May 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2013</study_first_posted>
  <last_update_submitted>May 12, 2013</last_update_submitted>
  <last_update_submitted_qc>May 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>osteoporosis</keyword>
  <keyword>postmenopausal</keyword>
  <keyword>patient compliance</keyword>
  <keyword>compliance</keyword>
  <keyword>diphosphonates</keyword>
  <keyword>bisphosphonates</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diphosphonates</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

